Suppr超能文献

中国疫苗产品走向全球:疫苗研发与质量控制。

Chinese vaccine products go global: vaccine development and quality control.

作者信息

Xu Miao, Liang Zhenglun, Xu Yinghua, Wang Junzhi

机构信息

Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes for Food and Drug Control, No.2, Tiantan Xili, Dongcheng District, Beijing 100050, People's Republic of China.

出版信息

Expert Rev Vaccines. 2015 May;14(5):763-73. doi: 10.1586/14760584.2015.1012503. Epub 2015 Feb 19.

Abstract

Through the continuous efforts of several generations, China has become one of the few countries in the world that is capable of independently addressing all the requirements by the Expanded Program on Immunization. Regulatory science is applied to continuously improve the vaccine regulatory system. Passing the prequalification by WHO has allowed Chinese vaccine products to go global. Chinese vaccine products not only secure disease prevention and control domestically but also serve the needs for international public health. This article describes the history of Chinese vaccine development, the current situation of Chinese vaccine industry and its contribution to the prevention and control of infectious diseases. We also share our experience of national quality control and vaccine regulation during the past decades. China's experience in vaccine development and quality control can benefit other countries and regions worldwide, including the developing countries.

摘要

经过几代人的不懈努力,中国已成为世界上少数几个有能力独立满足扩大免疫规划所有要求的国家之一。应用监管科学不断完善疫苗监管体系。通过世界卫生组织的预认证使中国疫苗产品走向全球。中国疫苗产品不仅保障了国内疾病防控,也满足了国际公共卫生需求。本文介绍了中国疫苗发展历程、中国疫苗产业现状及其对传染病防控的贡献。我们还分享了过去几十年国家质量控制和疫苗监管的经验。中国在疫苗研发和质量控制方面的经验可为包括发展中国家在内的全球其他国家和地区带来益处。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验